Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Cell Death and Disease

Topics

Biology

Biochemistry

Medicine

Cancer Oncology

Internal Medicine

Show all topics

DOI

10.1038/cddis.2012.181

License

CC-BY

Other Formats

PDF